Breaking News

Baxter Completes Expansion at Halle Facility

Adds freeze-drying capacity for commercial cytotoxic manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Baxter’s BioPharma Solutions business has completed its latest capacity expansion at its cytotoxic contract manufacturing facility in Halle/Westfalen, Germany. The expansion included the installation of an additional large-scale, commercial lyophilization unit to increase freeze-drying capacity to support commercial cytotoxic manufacturing capacity. The freeze dryer was designed to meet international manufacturing and regulatory requirements. “This latest investment clearly demonstr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters